Evidence map›Paper›PMID 31359358›Full record

ArticleInternational urology and nephrology2019

The protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro.

Tao Cao, Ricong Xu, Yi Xu, Yang Liu, Dongli Qi, Qijun Wan

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Acta pharmaceutica Sinica. B · 2024
    Review
  9. Enhanced production of cordycepin under solid-state fermentation of Cordyceps militaris by using combinations of grains/substrates.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  10. Article
  11. Review
  12. Research Progress ofJournal of inflammation research · 2023
    Review
  13. Review
  14. Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Molecular medicine reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tao CaoDepartment of Nephrology, The First Affiliated Hospital of Shenzhen University and Shenzhen Second People's Hospital, No. 3002 Sungang West Road, Futian District, Shenzhen, Guangdong, 518000, P.R. China. caotao1811@163.com.ORCID http://orcid.org/0000-0001-8713-8800
Ricong XuDepartment of Nephrology, The First Affiliated Hospital of Shenzhen University and Shenzhen Second People's Hospital, No. 3002 Sungang West Road, Futian District, Shenzhen, Guangdong, 518000, P.R. China.
Yi XuDepartment of Nephrology, The First Affiliated Hospital of Shenzhen University and Shenzhen Second People's Hospital, No. 3002 Sungang West Road, Futian District, Shenzhen, Guangdong, 518000, P.R. China.
Yang LiuDepartment of Nephrology, The First Affiliated Hospital of Shenzhen University and Shenzhen Second People's Hospital, No. 3002 Sungang West Road, Futian District, Shenzhen, Guangdong, 518000, P.R. China.
Dongli QiDepartment of Nephrology, The First Affiliated Hospital of Shenzhen University and Shenzhen Second People's Hospital, No. 3002 Sungang West Road, Futian District, Shenzhen, Guangdong, 518000, P.R. China.
Qijun WanDepartment of Nephrology, The First Affiliated Hospital of Shenzhen University and Shenzhen Second People's Hospital, No. 3002 Sungang West Road, Futian District, Shenzhen, Guangdong, 518000, P.R. China.
Shenzhen Second People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic nephropathy (DN) is one of the most serious chronic complications of diabetes mellitus (DM). Autophagy is an important physiological function for podocytes to maintain stability of intracellular environment. In this study, we planned to clarify the effect of Cordycepin, a traditional Chinese medicine, on DN and the related mechanisms.

methodsAll rats were randomly divided into normal control group, diabetic controls, low-dose group (10 mg/kg), medium-dose group (100 mg/kg), and high-dose group (500 mg/kg). The level of cholesterol, blood sugar, triglyceride, creatinine, and urine protein was examined through an automatic biochemistry analyser. Enzyme-linked immunosorbent assay (Elisa) was used to detect the level of IL-1β, IL-6, and IL-18. HE staining was used to examine histopathologic changes. TUNEL staining was used to detected cell apoptosis. The expression of fibrosis markers α-SMA, t-TG, and TIMP-1, apoptosis-related proteins cleaved-caspase3, Bax and Bcl-2, autophagy markers Beclin1, light chain 3 (LC3)I/II, and p62 were evaluated by western blot.

resultsThe level of cholesterol, blood sugar, triglyceride, creatinine, and urine protein in the diabetic controls was much higher than that in the normal control group. Obvious histopathology injuries were also found in DN model group. After Cordycepin treatment, all the above indexes were improved compared with the DN group and tissue damages were also alleviated. Further studies showed that Cordycepin suppressed cell apoptosis and renal fibrosis and rescued cell autophagy in DN rat model. Moreover, the results of our in vitro experiments showed that the addition of 3-methyladenine (3-MA, specific autophagy inhibitor) successfully abolished the protective effect of Cordycepin on renal fibrosis through inducing apoptosis and renal fibrosis. The above protective effects of Cordycepin were exhibited in a dose-dependent manner.

conclusionCordycepin participated in the modulation of cell apoptosis, fibrosis, and autophagy induction in DN. Our study for the first time revealed that Cordycepin had a certain therapeutic effect on DN in rats through autophagy induction.

Indexed as

AnimalsAutophagyDeoxyadenosinesDiabetic NephropathiesDisease Models, AnimalMaleRandom AllocationRatsRats, WistarcordycepinDeoxyadenosinesApoptosisAutophagyCordycepinDiabetic nephropathy

Identifiers

PMID31359358
OpenAlexW2966228008

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.